AMRI Albany Molecular Research, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Albany Molecular Research, Inc. (NASDAQGS: AMRI) stock prior to June 6, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Albany Molecular to The Carlyle Group and GTCR LLC for $21.75 per share. To learn more about the action and your rights, go to:

http://www.zlkdocs.com/AMRI-Info-Request-Form-ma-5860

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
07/06/2017

Underlying

AMRIAlbany Molecular Research, Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Albany Molecular Research, Inc.

Please Change Name Jonathan Kanarek ... (+2)
  • Please Change Name Jonathan Kanarek
  • CFA
EUR 159.06
AMRI Albany Molecula...

Moody's assigns B3 CFR to UIC Merger Sub, Inc. (dba Albany Molecular R...

Rating Action: Moody's assigns B3 CFR to UIC Merger Sub, Inc.. Global Credit Research- 19 Jul 2017. New York, July 19, 2017-- Moody's Investors Service, today assigned a B3 Corporate Family Rating and B3-PD Probability of Default Rating to UIC Merger Sub, Inc., which upon deal close will become Albany Molecular Research, Inc..

AMRI ALBANY MOLECULAR RESEARCH
INC.
07/19/17 July 19, 2017 5 EN
 PRESS RELEASE
Free
AMRI Albany Molecula...
INC.

INVESTOR ALERT: Brower Piven Commences an Investigation into the Propo...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Albany Molecular Research, Inc. (Nasdaq: AMRI) (“AMRI” or the “Company”) relating to the proposed buyout of AMRI by The Carlyle Group. Under the terms of the agreement, AMRI shareholders are anticipated to receive $21.75 in cash for each share of AMRI common stock held. The ...

June 13, 2017 1 EN
 PRESS RELEASE
Free
AMRI Albany Molecula...
INC.

The Law Offices of Vincent Wong Reminds Investors of an Investigation ...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Albany Molecular Research, Inc. (NASDAQGS:AMRI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to GTCR LLC and The Carlyle Group. Under the terms of the deal, Albany Molecular shareholders will receive $21.75 per share. The investigation concerns whether the Albany Molecular Board of Directors breached their fiduciary duties to Albany Molecular sto...

June 13, 2017 1 EN
MarketLine Department
  • MarketLine Department
EUR 311.72
AMRI Albany Molecula...

Albany Molecular Research, Inc. – Mergers & Acquisitions (M&A), Part...

Summary Pharmaceuticals and Healthcare Key Findings Pharmaceuticals and Healthcare Pharmaceuticals and Healthcare Reasons To Buys MarketLine Key Highlights United States

AMRI ALBANY MOLECULAR RESEARCH
INC.
06/13/17 June 13, 2017 115 EN
 PRESS RELEASE
Free
AMRI Albany Molecula...
INC.

The Law Offices of Vincent Wong Notifies Investors of an Investigation...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Albany Molecular Research, Inc. (NASDAQGS: AMRI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to GTCR LLC and The Carlyle Group. Under the terms of the deal, Albany Molecular shareholders will receive $21.75 per share. The investigation concerns whether the Albany Molecular Board of Directors breached their fiduciary duties to Albany Molecular st...

June 9, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch